Form 8-K - Current report:
SEC Accession No. 0001193125-26-202506
Filing Date
2026-05-04
Accepted
2026-05-04 07:07:33
Documents
61
Period of Report
2026-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20260504.htm   iXBRL 8-K 50135
2 EX-99.1 axsm-ex99_1.htm EX-99.1 248588
3 EX-99.2 axsm-ex99_2.htm EX-99.2 44510
4 GRAPHIC img36028404_0.gif GRAPHIC 10743
5 GRAPHIC axsm-ex99_2s1.jpg GRAPHIC 143417
6 GRAPHIC axsm-ex99_2s2.jpg GRAPHIC 823228
7 GRAPHIC axsm-ex99_2s3.jpg GRAPHIC 376128
8 GRAPHIC axsm-ex99_2s4.jpg GRAPHIC 229365
9 GRAPHIC axsm-ex99_2s5.jpg GRAPHIC 350318
10 GRAPHIC axsm-ex99_2s6.jpg GRAPHIC 332916
11 GRAPHIC axsm-ex99_2s7.jpg GRAPHIC 339268
12 GRAPHIC axsm-ex99_2s8.jpg GRAPHIC 288019
13 GRAPHIC axsm-ex99_2s9.jpg GRAPHIC 223653
14 GRAPHIC axsm-ex99_2s10.jpg GRAPHIC 121930
15 GRAPHIC axsm-ex99_2s11.jpg GRAPHIC 228641
16 GRAPHIC axsm-ex99_2s12.jpg GRAPHIC 252447
17 GRAPHIC axsm-ex99_2s13.jpg GRAPHIC 246801
18 GRAPHIC axsm-ex99_2s14.jpg GRAPHIC 206164
19 GRAPHIC axsm-ex99_2s15.jpg GRAPHIC 241165
20 GRAPHIC axsm-ex99_2s16.jpg GRAPHIC 121529
21 GRAPHIC axsm-ex99_2s17.jpg GRAPHIC 332813
22 GRAPHIC axsm-ex99_2s18.jpg GRAPHIC 351374
23 GRAPHIC axsm-ex99_2s19.jpg GRAPHIC 292710
24 GRAPHIC axsm-ex99_2s20.jpg GRAPHIC 276663
25 GRAPHIC axsm-ex99_2s21.jpg GRAPHIC 269660
26 GRAPHIC axsm-ex99_2s22.jpg GRAPHIC 306138
27 GRAPHIC axsm-ex99_2s23.jpg GRAPHIC 252990
28 GRAPHIC axsm-ex99_2s24.jpg GRAPHIC 292419
29 GRAPHIC axsm-ex99_2s25.jpg GRAPHIC 269579
30 GRAPHIC axsm-ex99_2s26.jpg GRAPHIC 123926
31 GRAPHIC axsm-ex99_2s27.jpg GRAPHIC 271633
32 GRAPHIC axsm-ex99_2s28.jpg GRAPHIC 315558
33 GRAPHIC axsm-ex99_2s29.jpg GRAPHIC 290659
34 GRAPHIC axsm-ex99_2s30.jpg GRAPHIC 250414
35 GRAPHIC axsm-ex99_2s31.jpg GRAPHIC 332764
36 GRAPHIC axsm-ex99_2s32.jpg GRAPHIC 258756
37 GRAPHIC axsm-ex99_2s33.jpg GRAPHIC 226539
38 GRAPHIC axsm-ex99_2s34.jpg GRAPHIC 269905
39 GRAPHIC axsm-ex99_2s35.jpg GRAPHIC 309654
40 GRAPHIC axsm-ex99_2s36.jpg GRAPHIC 279860
41 GRAPHIC axsm-ex99_2s37.jpg GRAPHIC 230811
42 GRAPHIC axsm-ex99_2s38.jpg GRAPHIC 362545
43 GRAPHIC axsm-ex99_2s39.jpg GRAPHIC 227179
44 GRAPHIC axsm-ex99_2s40.jpg GRAPHIC 265223
45 GRAPHIC axsm-ex99_2s41.jpg GRAPHIC 324334
46 GRAPHIC axsm-ex99_2s42.jpg GRAPHIC 261959
47 GRAPHIC axsm-ex99_2s43.jpg GRAPHIC 342176
48 GRAPHIC axsm-ex99_2s44.jpg GRAPHIC 217231
49 GRAPHIC axsm-ex99_2s45.jpg GRAPHIC 272756
50 GRAPHIC axsm-ex99_2s46.jpg GRAPHIC 259609
51 GRAPHIC axsm-ex99_2s47.jpg GRAPHIC 348856
52 GRAPHIC axsm-ex99_2s48.jpg GRAPHIC 311732
53 GRAPHIC axsm-ex99_2s49.jpg GRAPHIC 110473
  Complete submission text file 0001193125-26-202506.txt   19266375

Data Files

Seq Description Document Type Size
54 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20260504.xsd EX-101.SCH 23858
64 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20260504_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 26934592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)